We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fibrin Sealants Effectively Relieve Pain Following Laparoscopic Cholecystectomy

By HospiMedica International staff writers
Posted on 12 Jan 2010
Implanting fibrin sealant with sustained-release ropivacaine in the gallbladder bed safely and effectively relieves pain after laparoscopic cholecystectomy (LC), according to a new study.

Researchers at Capital Medical University (Beijing, China) studied 60 patients who underwent LC and were randomly divided into three equal groups: group A, who underwent implantation of fibrin sealant in the gallbladder bed; group B, who underwent implantation of fibrin sealant carrying ropivacaine in the gallbladder bed; and group C, who were irrigated with normal saline in the gallbladder bed. More...
Patients with previous major upper abdominal surgeries, choledocholithiasis, acute cholecystitis, or conversion to open cholecystectomy were excluded from the study. The researchers evaluated postoperative pain, and pain relief was assessed by visual analog scale (VAS) scoring.

The results showed that 81.7% of patients had visceral pain, 50% experienced parietal pain, and 26.7% reported shoulder pain following LC. Visceral pain was significantly less in group B patients than in the other groups, and only one patient within group B experienced shoulder pain. The mean VAS score in group B patients was also lower than that of the patients in the other groups. The study was published in the December 14, 2009, issue of World Journal of Gastroenterology.

"The VAS score for the patients with fibrin sealant alone implanted in the gallbladder bed was less than that of the control group, although the differences were not statistically significant,” concluded lead author Jian-Zhu Fu, M.D., and colleagues of the department of general surgery. "This suggests that the gallbladder bed with implanted fibrin sealant alone may lead to a slight relief in postoperative pain.”

The incidence of pain after laparoscopy is attributed to the carbon dioxide gas (CO2) used to induce pneumoperitoneum. CO2 remains in the peritoneal cavity for several days after surgery, causing stretching of the phrenic nerve endings, local hypothermia, and diaphragmatic irritation via carbonic acid. The pain can be divided into three components, namely, visceral, parietal, and shoulder pain, with different intensities and time courses. LC is mainly associated with visceral pain, which may refer to the shoulder in 35% to 60% of cases. Various treatments have been proposed to make LC as pain-free as possible; since fibrin sealant has been used to release medicines slowly at a fixed site as an adjunct to surgical procedures and to control diffuse slow bleeding over large surfaces, it is reasonable to assume it could also serve in LC.

Related Links:

Capital Medical University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.